Published in Heart Vessels on April 04, 2013
Patient radiation dose reduction using an X-ray imaging noise reduction technology for cardiac angiography and intervention. Heart Vessels (2015) 0.86
Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease. Heart Vessels (2015) 0.86
Clinical characteristics and intravascular ultrasound findings of culprit lesions in elderly patients with acute coronary syndrome. Heart Vessels (2014) 0.86
Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure. Heart Vessels (2013) 0.85
A relative difference in systolic blood pressure between arms by synchronal measurement and conventional cardiovascular risk factors are associated with the severity of coronary atherosclerosis. Heart Vessels (2015) 0.83
Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients. Heart Vessels (2015) 0.83
Deficiency of Senescence Marker Protein 30 Exacerbates Cardiac Injury after Ischemia/Reperfusion. Int J Mol Sci (2016) 0.75
In-hospital clinical outcomes of elderly patients (≥60 years) undergoing primary percutaneous coronary intervention. Int J Clin Exp Med (2015) 0.75
Four cases of investigational therapy with interleukin-11 against acute myocardial infarction. Heart Vessels (2016) 0.75
Hyponatremia at discharge as a predictor of 12-month clinical outcomes in hospital survivors after acute myocardial infarction. Heart Vessels (2016) 0.75
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet (2001) 6.26
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet (2001) 4.65
Survival after coronary revascularization in the elderly. Circulation (2002) 3.17
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA (1988) 2.30
Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol (2000) 2.12
Cardiorenal syndrome: new perspectives. Circulation (2010) 2.03
Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA (2011) 1.88
Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes. Circulation (2007) 1.59
Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J (2011) 1.59
Exacerbation of vasotonic angina pectoris by propranolol. Circulation (1982) 1.31
The clinical challenge of cardiorenal syndrome. Circulation (2004) 1.28
Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. J Am Coll Cardiol (1998) 1.08
Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation (2008) 0.94
Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J (2008) 0.94
Acute and intermediate-term results of percutaneous coronary stenting in octogenarian patients. Int J Cardiovasc Intervent (2003) 0.83
Clinical outcome after acute coronary syndrome in Japanese patients: an observational cohort study. J Cardiol (2009) 0.82
Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina. Ann Thorac Surg (2005) 0.78
Assessment of acute myocardial infarction in Japan by the Japanese Coronary Intervention Study (JCIS) Group. Circ J (2004) 0.77
Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. J Cardiol (2013) 3.36
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med (2009) 2.25
Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. J Biol Chem (2004) 1.91
Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J (2009) 1.80
Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J (2011) 1.75
Dabigatran in clinical practice for atrial fibrillation with special reference to activated partial thromboplastin time. Circ J (2012) 1.66
Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J (2011) 1.59
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J (2008) 1.57
Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J (2009) 1.56
Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry. Circ J (2014) 1.49
Validation of CHA₂DS₂-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry. Circ J (2014) 1.47
Incidence and impact on midterm outcome of controlled subintimal tracking in patients with successful recanalisation of chronic total occlusions: J-PROCTOR registry. EuroIntervention (2014) 1.46
Relation between oscillatory breathing and cardiopulmonary function during exercise in cardiac patients. Circ J (2012) 1.45
Use of Warfarin in Elderly Patients With Non-Valvular Atrial Fibrillation - Subanalysis of the J-RHYTHM Registry. Circ J (2015) 1.45
Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment. Circ J (2015) 1.45
Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation. Circ J (2014) 1.44
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin - Insights From the ENGAGE AF-TIMI 48 Trial. Circ J (2015) 1.44
Identification and localization of the sperm CRISP family protein CiUrabin involved in gamete interaction in the ascidian Ciona intestinalis. Mol Reprod Dev (2011) 1.43
Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry. Circ J (2015) 1.41
Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease. J Cardiol (2010) 1.41
An expiratory assist during spontaneous breathing can compensate for endotracheal tube resistance. Anesth Analg (2009) 1.41
Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation – subanalysis of the J-RHYTHM Registry. Circ J (2014) 1.40
Effects of supplemental O2 inhalation on cerebral oxygenation during exercise in patients with left ventricular dysfunction. Circ J (2007) 1.40
Electrocardiography characteristics of isolated non-compaction of ventricular myocardium in Japanese adult patients. Circ J (2010) 1.39